Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Darifenacin hydrobromide | 133099-07-7 | MFCD08141803 | 99.8% | C28H31BrN2O2 | 50 MG
Supplier: Medchemexpress LLC HYA001250MG
Darifenacin hydrobromide is a selective and orally active M3 muscarinic receptor (M3R) antagonist. It exhibits high specificity for M3R, binding >20-fold more specifically than to other muscarinic receptors. This compound is valuable for studying urinary incontinence and other symptoms associated with an overactive bladder. Additionally, it has demonstrated potential in inhibiting tumor growth in colorectal cancer cells, suggesting anti-tumor effects.
- Selective and orally active M3 muscarinic receptor antagonist
- High specificity for M3R
- Useful in studying urinary incontinence and overactive bladder
- Inhibits tumor growth in colorectal cancer cells
- Exhibits anti-tumor effects
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?